Obesity, Overweight, Quality of Life
Conditions
Keywords
Energy, Presenteeism, Absenteeism, Cardiometabolic health, Obesity, Overweight, Weight Loss, Quality of Life, Weight Control, Eating Behavior, Food Cravings, Hunger, Worksite Wellness
Brief summary
Worksites offer attractive locations for reducing the national prevalence of overweight and obesity. Interventions that are both effective and sustainable for producing long-term changes in health and employee wellness are urgently needed. In an 18-month worksite randomized controlled trial in 12 worksites, this study will test two lifestyle approaches designed to facilitate behavior modification for achieving long-term improvements in health and quality of life. Worksites randomized to the immediate intervention arm will receive the two on-site wellness programs and the randomized control sites will participate in outcomes assessments for the initial 6-month period, after which participants will receive vouchers to participate in the program of their choice. The primary focus of the worksite wellness study is to identify ways to improve health-related quality of life, with a particular focus on a decrease in cardiometabolic risk factors, including weight, improved weight-related wellness, and improved energy level in work and life. The two interventions will be separately tested against the control condition in intention-to-treat models and with a completers analysis.
Interventions
BEHAVIORALThe iDiet® (also called Healthy Weight for Living when used as a not-for-profit intervention) with Food
The intensive iDiet® group behavioral weight loss program will be delivered in person at the worksite or by videoconference and with support of the program's web platform. This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader. Over time support will be provided online rather than in live meetings. The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain. Half of the participants per worksite receiving the iDiet® intervention will be randomized to receive commercial dried food products (partial supply) from Yevo Intl., which are designed to help with weight control and health.
BEHAVIORALThe iDiet® (also called Healthy Weight for Living when used as a not-for-profit intervention) with Voucher
The intensive iDiet® group behavioral weight loss program delivered in person at the worksite or by videoconference and with support of the program's web platform. This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader. Over time support will be provided online rather than in live meetings. The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain. Half of the participants per worksite receiving the Diet® intervention will be randomized to receive gift cards monthly for the first 6 months to purchase foods at their local grocery store (partial costs).
BEHAVIORALHuman Performance Institute©
The Human Performance Institute© (HPI) training workshop is a comprehensive individual development training program that focuses on the concept of energy management. The primary aim of this program is to help individuals develop attitudes, habits, and behaviors that increase their levels of daily energy, life satisfaction, and overall functioning. The course is delivered at an off-site location over 2.5 days, by 3 coaches, in a group format of 25 - 32 participants (with employees from more than one worksite per group).
Sponsors
Tufts University
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Willingness to sign an informed consent form 2. Willingness to provide release from his/her physician before starting the intervention program-a requirement for each of the 3 wellness programs 3. Willingness to provide email identification (ID) and contact information to the commercial program facilitators to receive program materials and other feedback related to program progress 4. Willingness to complete outcome assessments and self-monitoring in order to track intervention effectiveness 5. BMI ≥ 20 kg/m2 and \< 50 kg/m2 at screening, if participant opts into the HPI arm 6. BMI ≥ 25 kg/m2 and \< 50 kg/m2 at screening, if participant opts into the weight loss arm
Exclusion criteria
1. Employees who are temporary contract workers or employees who work remotely most of the time 2. \< 21 years of age 3. Participation in a weight loss program or intensive wellbeing program at time of enrollment 4. Pregnant or lactating (per self-reports, now or intended during study) 5. Prior weight loss surgery or a medical complication that would prevent full participation 6. Multiple severe dietary intolerances (e.g. gluten combined with dairy or meat) which would reduce intervention adherence 7. Non-English speaking 8. Individuals who have lost \> 15 pounds in the past 6 months 9. Mobility limitations (inhibiting the ability to stand on one's own or get on and off of the scale) 10. Major diseases including active cancer or cardiovascular disease 11. BMI \< 25 kg/m2 or ≥ 50 kg/m2 at screening, for those that opt-in to the weight-loss group 12. BMI \<20 kg/m2 or ≥ 50 kg/m2 at screening, for those that opt-in to the HPI group For those interested in the weight loss intervention, additional
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight (iDiet/Healthy Weight for Living arms) | 1.5 years | Fasted measurements of weight obtained in duplicate to ±0.1 kg at baseline, 6, 12, and 18 months using the TANITA TBF-300A. |
| Quality of Life (HPI arm) | 1.5 years | Assessed by the RAND Short Form 36 Health Survey (SF-36) at baseline, 6, 12, and 18 months. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Triglycerides | 1.5 years | Triglycerides measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System (fasted lipid panel). |
| Glucose | 1.5 years | Fasting blood glucose measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System. |
| Hemoglobin A1c | 1.5 years | HbA1c measured at baseline, 6, 12, and 18 months using the Siemens DCA Vantage, which requires 1 microliter of blood (fasted measurement). |
| Eating behavior (Food Preferences) | 1.5 years | Assessed by the Food Preferences Questionnaire (self-administered) at baseline, 6, 12, and 18 months. |
| Eating behavior (Three-Factor Eating) | 1.5 years | Assessed by the Three-Factor Eating Questionnaire (self-administered) at baseline, 6, 12, and 18 months. |
| Eating behavior (Food Cravings) | 1.5 years | Assessed by the Food Cravings Questionnaire - Trait (self-administered) at baseline, 6, 12, and 18 months. |
| Blood pressure | 1.5 years | Systolic and diastolic blood pressure (mm Hg) measured to the nearest 1 mm Hg at baseline, 6, 12, and 18 months using a validated automated monitor (3 fasted measurements, 5 minutes apart, after 5 minutes of quiet sitting). |
| Mood | 1.5 years | Assessed by the Profile of Mood States (self-administered) at baseline, 6, 12, and 18 months. Variables include anger-hostility, depression-dejection, fatigue-inertia, and vigor-activity. |
| Physical Activity | 1.5 years | Assessed by the International Physical Activity Questionnaire (self-administered) at baseline, 6, 12, and 18 months. |
| Well-being | 1.5 years | Assessed by the Ryff Purpose in Life scale (self-administered) at baseline, 6, 12, and 18 months. |
| Productivity | 1.5 years | Assessed by the Work Productivity and Impairment scale (self-administered) at baseline, 6, 12, and 18 months. |
| Sleep | 1.5 years | Assessed by the Medical Outcomes Study Sleep Questionnaire (self-administered) at baseline, 6, 12, and 18 months. |
| Depression | 1.5 years | Assessed by the Center for Epidemiological Studies Depression Scale (self-administered) at baseline, 6, 12, and 18 months. |
| Cholesterol | 1.5 years | Total cholesterol, high-density lipoprotein, and low-density lipoprotein measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System, which requires 40 microliters of blood (fasted lipid panel). |
Countries
United States
Outcome results
None listed